Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

HemoCept Inc.50 enrolled

Overview

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pulmonary Hypertension Congestive Heart Failure(CHF)Valve Disease, Heart

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures. * Subjects can be any gender but must be age 18 or older. * Subject is able and willing to provide informed consent and HIPAA authorization. * Subject is able and willing to meet all study requirements. * Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible) Exclusion Criteria: * Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Locations (1)

Boulder Heart

Boulder, Colorado, United States

RECRUITING

Outcomes

Primary Outcomes

Association between device measurements and Pulmonary Capillary Wedge Pressure

The correlation of HemoCept device measurements to Pulmonary Capillary Wedge Pressure (PCWP) measured during right heart catheterization.

Time frame: Day 1

Central Contacts

Katharine Adkins

CONTACT

303-442-2395 kathari.adkins@bch.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.